{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:39:20Z","timestamp":1793813960889,"version":"4.6.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T00:00:00Z","timestamp":1345507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2415-12-43","type":"journal-article","created":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T12:50:33Z","timestamp":1345553433000},"source":"Crossref","is-referenced-by-count":48,"title":["A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma"],"prefix":"10.1186","volume":"12","author":[{"given":"Fiammetta Maria","family":"Bozzani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmene","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Jofre-Bonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Kuper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,21]]},"reference":[{"key":"296_CR1","first-page":"844","volume":"82","author":"S Resnikoff","year":"2004","unstructured":"Resnikoff S, Pascolini D, Etya'ale D, et al: Global data on visual impairment in the year 2002. Bulletin of the World Health Organization. 2004, 82: 844-851.","journal-title":"Bulletin of the World Health Organization"},{"key":"296_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT: The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006, 90: 262-267. 10.1136\/bjo.2005.081224.","journal-title":"Br J Ophthalmol"},{"key":"296_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/09286580600760539","volume":"13","author":"H Kuper","year":"2006","unstructured":"Kuper H, Jofre-Bonet M, Gilbert C: Economic evaluation for ophtalmologists. Ophtalmic Epidemiol. 2006, 13: 393-401. 10.1080\/09286580600760539.","journal-title":"Ophtalmic Epidemiol"},{"key":"296_CR4","doi-asserted-by":"crossref","unstructured":"Brazier J, Deverill M, Green C, et al: A review of the use of health status measures in economic evaluation. Health Technol Assess. 1999, 3 (9):","DOI":"10.3310\/hta3090"},{"key":"296_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/09286580801939346","volume":"15","author":"SM Kymes","year":"2008","unstructured":"Kymes SM: An introduction to decision analysis in the economic evaluation of the prevention and treatment of vision-related disease. Ophtalmic Epidemiol. 2008, 15: 76-83. 10.1080\/09286580801939346.","journal-title":"Ophtalmic Epidemiol"},{"key":"296_CR6","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ajo.2007.02.022","volume":"143","author":"R McKean-Cowdin","year":"2007","unstructured":"McKean-Cowdin R, Varma R, Wu J, et al: Severity of visual field loss and health-related quality of life. Am J Ophthalmol. 2007, 143: 1013-1023. 10.1016\/j.ajo.2007.02.022.","journal-title":"Am J Ophthalmol"},{"key":"296_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","volume":"10","author":"R Jaeschke","year":"1989","unstructured":"Jaeschke R, Singer J, Guyatt GH: Measurement of health status. Ascertaining the minimal clinically important difference. Contr Clin Trials. 1989, 10: 407-415. 10.1016\/0197-2456(89)90005-6.","journal-title":"Contr Clin Trials"},{"key":"296_CR8","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1167\/iovs.07-0559","volume":"49","author":"PA Aspinall","year":"2008","unstructured":"Aspinall PA, Johnson ZK, Azuara-Blanco A, et al: Evaluation of quality of life and priorities of patients with glaucoma. Invest Ophthalmol Vis Sci. 2008, 49: 1907-1915. 10.1167\/iovs.07-0559.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"296_CR9","first-page":"3393","volume":"43","author":"AT Broman","year":"2002","unstructured":"Broman AT, Munoz B, Rodriguez J, et al: The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophtalmol Vis Sci. 2002, 43: 3393-3398.","journal-title":"Invest Ophtalmol Vis Sci"},{"key":"296_CR10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2147\/OPTH.S6024","volume":"3","author":"K Evans","year":"2009","unstructured":"Evans K, Law SK, Walt J, et al: The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration. Clin Ophtalmol. 2009, 3: 433-445.","journal-title":"Clin Ophtalmol"},{"key":"296_CR11","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1136\/bjo.2005.068858","volume":"89","author":"V Gupta","year":"2005","unstructured":"Gupta V, Srinivasan G, Mei SS, et al: Utility values among glaucoma patients: an impact on the quality of life. Br J Ophthalmol. 2005, 89: 1241-1244. 10.1136\/bjo.2005.068858.","journal-title":"Br J Ophthalmol"},{"key":"296_CR12","first-page":"301","volume":"99","author":"HD Jampel","year":"2001","unstructured":"Jampel HD: Glaucoma patients' assessment of their visual function and quality of life. Trans Am Ophtalmol Soc. 2001, 99: 301-317.","journal-title":"Trans Am Ophtalmol Soc"},{"key":"296_CR13","first-page":"753","volume":"96","author":"RP Mills","year":"1998","unstructured":"Mills RP: Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis. Trans Am Ophtalmol Soc. 1998, 96: 753-812.","journal-title":"Trans Am Ophtalmol Soc"},{"key":"296_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0895-4356(02)00609-1","volume":"56","author":"JA Kopec","year":"2003","unstructured":"Kopec JA, Willison KD: A comparative review of four preference-weighted measures of health-related quality of life. J Clin Epidemiol. 2003, 56: 317-325. 10.1016\/S0895-4356(02)00609-1.","journal-title":"J Clin Epidemiol"},{"key":"296_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/bmj.b2577","volume":"339","author":"P Dolan","year":"2009","unstructured":"Dolan P, Lee H, Kling D, et al: How does NICE value health?. BMJ. 2009, 339: 371-373.","journal-title":"BMJ"},{"key":"296_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s11136-009-9499-6","volume":"18","author":"N Payakachat","year":"2009","unstructured":"Payakachat N, Summers KH, Pleil AM, et al: Predicting EQ-5D utility scores from the 25-item National Eye Institute Visual Function Questionnaire (NEI-VFQ) in patients with age-related macular degeneration. Qual Life Res. 2009, 18: 801-813. 10.1007\/s11136-009-9499-6.","journal-title":"Qual Life Res"},{"key":"296_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/IJG.0b013e31814b9693","volume":"17","author":"R Hernandez","year":"2008","unstructured":"Hernandez R, Rabindranath K, Fraser C, et al: Screening for open angle glaucoma: systematic review of cost-effectiveness studies. J Glaucoma. 2008, 17: 159-168. 10.1097\/IJG.0b013e31814b9693.","journal-title":"J Glaucoma"},{"key":"296_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/01658100701473267","volume":"14","author":"DB Rein","year":"2007","unstructured":"Rein DB, Wirth KE, Johnson CA, et al: Estimating quality-adjusted life-year losses associated with visual field deficits using methodological approaches. Ophthalmic Epidemiol. 2007, 14: 258-264. 10.1080\/01658100701473267.","journal-title":"Ophthalmic Epidemiol"},{"key":"296_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1600-0420.2005.00621.x","volume":"84","author":"G Kobelt","year":"2006","unstructured":"Kobelt G, Jonsson B, Bergstrom A, et al: Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden. Acta Ophthalmol Scand. 2006, 84: 363-371. 10.1111\/j.1600-0420.2005.00621.x.","journal-title":"Acta Ophthalmol Scand"},{"key":"296_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00061198-200304000-00009","volume":"12","author":"P Nelson","year":"2003","unstructured":"Nelson P, Aspinall P, Papasouliotis O, et al: Quality of life in glaucoma and its relationship with visual function. J Glaucoma. 2003, 12: 139-150. 10.1097\/00061198-200304000-00009.","journal-title":"J Glaucoma"},{"key":"296_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/ICU.0b013e32832401a9","volume":"20","author":"P Ramulu","year":"2009","unstructured":"Ramulu P: Glaucoma and disability: which tasks are affected and at what stage of disease?. Curr Op Ophthalmol. 2009, 20: 92-98. 10.1097\/ICU.0b013e32832401a9.","journal-title":"Curr Op Ophthalmol"},{"key":"296_CR22","volume-title":"HEDS Discussion paper 11\/03. A review of generic preference-based measures of health-related quality of life in visual disorders","author":"J Tosh","year":"2011","unstructured":"Tosh J, Brazier J, Evans P, Longworth L: HEDS Discussion paper 11\/03. A review of generic preference-based measures of health-related quality of life in visual disorders. 2011, The University of Sheffield"},{"key":"296_CR23","first-page":"233","volume":"18","author":"Y Alavi","year":"2011","unstructured":"Alavi Y, Jofre-Bonet M, Bunce C, et al: Developing and algorithm to convert routine measures of vision into utility values for glaucoma.Ophtalmic. Epidemiology. 2011, 18: 233-243.","journal-title":"Epidemiology"},{"key":"296_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00417-004-0984-x","volume":"243","author":"DP Crabb","year":"2005","unstructured":"Crabb DP, Viswanathan AC: Integrated visual fields: a new approach to measuring the binocular field of view and visual disability. Graefes Arch Clin Exp Ophthalmol. 2005, 243: 210-216. 10.1007\/s00417-004-0984-x.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"296_CR25","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/S0161-6420(97)30173-0","volume":"104","author":"CM Birt","year":"1997","unstructured":"Birt CM, Shin DH, Samudrala V, et al: Analysis of reliability indices from Humphrey visual field tests in an urban glaucoma population. Ophthalmology. 1997, 104: 1126-1130.","journal-title":"Ophthalmology"},{"key":"296_CR26","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, Feltgen N, Burau H, et al: Visual acuities \"hand motion\" and \"counting fingers\" can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006, 47: 1236-1240. 10.1167\/iovs.05-0981.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"296_CR27","unstructured":"RAND's Partners In Care: Depression screener. Available at: http:\/\/www.rand.org\/content\/dam\/rand\/www\/external\/health\/surveys_tools\/depression\/screener_eng.pdf ,"},{"key":"296_CR28","volume-title":"The National Statistics socio-economic Classification: User Manual","author":"Office for National Statistics","year":"2005","unstructured":"Office for National Statistics: Deriving NS-SEC: Self-coded method. The National Statistics socio-economic Classification: User Manual. 2005, Pallgrave Macmillan, London"},{"key":"296_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F: EQ-5D: a measure of health status from EuroQol group. Ann Med. 2001, 33: 337-343. 10.3109\/07853890109002087.","journal-title":"Ann Med"},{"key":"296_CR30","unstructured":"Ware JE: Available at: http:\/\/www.sf-36.org\/tools\/sf36.shtml ,"},{"key":"296_CR31","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/S0161-6420(02)00993-4","volume":"109","author":"MR Wilson","year":"1998","unstructured":"Wilson MR, Coleman AL, Yu F, et al: Functional status and well being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. Ophthalmology. 1998, 109: 1018-1022.","journal-title":"Ophthalmology"},{"key":"296_CR32","unstructured":"Brazier JE, Rowen D, Hanmer J: Revised SF-6D scoring programmes: a summary of improvements. Patient-reported Outcomes Newsletter. Available at: http:\/\/www.pro-newsletter.com\/images\/PDF_articles\/sf-6d.pdf ,"},{"key":"296_CR33","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S0161-6420(03)00254-9","volume":"110","author":"MM Brown","year":"2003","unstructured":"Brown MM, Brown GC, Sharma S, et al: Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology. 2003, 110: 1076-1081. 10.1016\/S0161-6420(03)00254-9.","journal-title":"Ophthalmology"},{"key":"296_CR34","first-page":"109","volume":"99","author":"GC Brown","year":"2001","unstructured":"Brown GC, Brown MM, Sharma S, Beauchamp G, Hollands H: The reproducibility of ophthalmic utility values. Trans Am Ophtalmol Soc. 2001, 99: 109-203.","journal-title":"Trans Am Ophtalmol Soc"},{"key":"296_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0008-4182(01)80041-7","volume":"36","author":"H Hollands","year":"2001","unstructured":"Hollands H, Lam M, Pater J, Albiani D, Brown GC, Brown M, et al: Reliability of the time trade-off technique of utility assessment in patients with retinal disease. Can J Ophthalmol-J Can D Ophtalmologie. 2001, 36: 202-209.","journal-title":"Can J Ophthalmol-J Can D Ophtalmologie"},{"key":"296_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/archopht.118.1.47","volume":"118","author":"GC Brown","year":"2000","unstructured":"Brown GC, Sharma S, Brown MM, Kistler J: Utility values and age-related macular degeneration. Arch Ophtalmol. 2000, 118: 47-51. 10.1001\/archopht.118.1.47.","journal-title":"Arch Ophtalmol"},{"key":"296_CR37","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0161-6420(03)00462-7","volume":"110","author":"RM Schiffman","year":"2003","unstructured":"Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W: Utility assessment among patients with dry eye disease. Ophthalmology. 2003, 110: 1412-1419. 10.1016\/S0161-6420(03)00462-7.","journal-title":"Ophthalmology"},{"key":"296_CR38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/bjo.86.5.493","volume":"86","author":"S Sharma","year":"2002","unstructured":"Sharma S, Brown GC, Brown MM, Hollands H, Robins R, Shah GK: Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophtalmol. 2002, 86: 493-496. 10.1136\/bjo.86.5.493.","journal-title":"Br J Ophtalmol"},{"key":"296_CR39","volume-title":"The National Eye Institute 25-item Visual Function Questionnaire (VFQ-25). Version","author":"CM Mangione","year":"2000","unstructured":"Mangione CM: The National Eye Institute 25-item Visual Function Questionnaire (VFQ-25). Version. 2000, Available at: http:\/\/www.nei.nih.gov\/resources\/visionfunction\/manual_cm2000.pdf ,"},{"key":"296_CR40","volume-title":"Guide to the methods of technology appraisal","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2008","unstructured":"National Institute for Health and Clinical Excellence (NICE): Guide to the methods of technology appraisal. 2008, London: National Institute for Health and Clinical Excellence"},{"key":"296_CR41","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, Bonsel G, Badia X: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5\u2009L). Qual Life Res. 2011, 20: 1727-1736. 10.1007\/s11136-011-9903-x.","journal-title":"Qual Life Res"},{"key":"296_CR42","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s11136-004-7713-0","volume":"14","author":"SJ Walters","year":"2005","unstructured":"Walters SJ, Brazier JE: Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005, 14: 1523-1532. 10.1007\/s11136-004-7713-0.","journal-title":"Qual Life Res"},{"key":"296_CR43","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jval.2011.08.002","volume":"15","author":"J Tosh","year":"2012","unstructured":"Tosh J, Brazier J, Evans P, Longworth L: A review of generic preference-based measures of health-related quality of life in visual disorders. Value in Health. 2012, 15: 118-127. 10.1016\/j.jval.2011.08.002.","journal-title":"Value in Health"},{"key":"296_CR44","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1167\/iovs.05-0072","volume":"46","author":"M Espallargues","year":"2005","unstructured":"Espallargues M, Czoski-Murray CJ, Bansback NJ, et al: The impact of age-related macular degeneration on health status utility values. Invest Ophthalmol Vis Sci. 2005, 46: 4016-4023. 10.1167\/iovs.05-0072.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"296_CR45","first-page":"592","volume":"35","author":"MJ Harrison","year":"2008","unstructured":"Harrison MJ, Davies LM, Bansback NJ, et al: The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review. J Rheumatol. 2008, 35: 592-602.","journal-title":"J Rheumatol"},{"key":"296_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11136-008-9429-z","volume":"18","author":"A Szende","year":"2009","unstructured":"Szende A, Leidy NK, et al: Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D. Qual Life Res. 2009, 18: 267-272. 10.1007\/s11136-008-9429-z.","journal-title":"Qual Life Res"},{"key":"296_CR47","volume-title":"Book Thinking about it: thoughts about health and valuing QALYs","author":"P Dolan","year":"2010","unstructured":"Dolan P: Thinking about it: thoughts about health and valuing QALYs. Book Thinking about it: thoughts about health and valuing QALYs. 2010, City"},{"key":"296_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bjo.2007.136150","volume":"93","author":"N Black","year":"2009","unstructured":"Black N, Browne J, van der Meulen J, et al: Is there overutilisation of cataract surgery in England?. Br J Ophtalmol. 2009, 93: 13-17. 10.1136\/bjo.2007.136150.","journal-title":"Br J Ophtalmol"},{"key":"296_CR49","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s11136-010-9649-x","volume":"19","author":"U Ravens-Sieberer","year":"2010","unstructured":"Ravens-Sieberer U, Wille N, Badia X, et al: Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res. 2010, 19: 887-897. 10.1007\/s11136-010-9649-x.","journal-title":"Qual Life Res"},{"key":"296_CR50","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0277-9536(97)00057-9","volume":"45","author":"A Robinson","year":"1997","unstructured":"Robinson A, Dolan P, Williams A: Valuing health states using the VAS and TTO: what lies behind the numbers?. Soc Sci Med. 1997, 45: 1289-1297. 10.1016\/S0277-9536(97)00057-9.","journal-title":"Soc Sci Med"},{"key":"296_CR51","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ophtha.2007.06.008","volume":"115","author":"BS Lee","year":"2008","unstructured":"Lee BS, Kymes SM, Nease RF, et al: The impact of anchor point on utilities for 5 common ophthalmic diseases. Ophthalmology. 2008, 115: 898-903 e894. 10.1016\/j.ophtha.2007.06.008.","journal-title":"Ophthalmology"},{"key":"296_CR52","volume-title":"Book UK population norms for EQ-5D","author":"P Kind","year":"1999","unstructured":"Kind P, Hardman G, Macran S: UK population norms for EQ-5D. Book UK population norms for EQ-5D. 1999"},{"key":"296_CR53","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002, 21: 271-292. 10.1016\/S0167-6296(01)00130-8.","journal-title":"J Health Econ"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-12-43\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-12-43.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-12-43","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-12-43.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T21:01:19Z","timestamp":1562101279000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-12-43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,21]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["296"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-12-43","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,21]]},"article-number":"43"}}